Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-26-000008

Chief Scientific Officer gave up 3,413 shares (to pay taxes)

  • Chief Scientific Officer acquired 6,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Or Yat Sun · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Grant or award : show line 1 in the form +1,650 373,042 D
2026-02-12 Grant or award : show line 2 in the form +5,225 378,267 D
2026-02-12 Shares withheld for taxes : show line 3 in the form −3,413 $14.25 $48,635 374,854 D
Loading xslF345X05/form4.xml…